Marijuana and Prescriptions

Bipartisan Letter To Congressional Leadership Urges Continued Protections For Medical Marijuana Programs

Today, sixty-six members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.

Marijuana reduces prescriptions

Trump’s Commission Denies Evidence That Cannabis Can Mitigate Opioid Abuse

Despite the growing body of scientific evidence showing that cannabis access is associated with reductions in opioid use and mortality, the Chairman of the White House’s Commission on Combating Drug Addiction and the Opioid Crisis today called upon the President to reject any efforts to acknowledge marijuana’s promising role in mitigating opioid abuse and dependency.

Cannabis Legislation

#ACT: Medical Marijuana Could Be On The Line

Protections for the medical marijuana markets that are now legal in 30 states are set to expire on December 8th. After that, over 2 million registered patients’ continued access to their medication will rely on the prohibitionist whims of Attorney General Jeff Sessions, who has been lobbying aggressively for the ability to use the full force of the Justice Department to interfere with their operations.

Marijuana and Liver Disease

Study: Cannabis Use Inversely Associated With Fatty Liver Disease

Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. “Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors,” authors determined. “[W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”

Marijuana or Opioids

Study: Colorado’s Adult Use Cannabis Access Law Associated With Reductions In Opioid Deaths

Retail cannabis distribution in Colorado is associated with a reduction in opioid-related mortality, according to data published online ahead of print in The American Journal of Public Health. Authors reported: “Colorado’s legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado.”

Marijuana and Veterans

VA Secretary Shulkin Still Hasn’t Responded to The American Legion’s Call for Marijuana Research

The Legion recently ramped up their efforts to convince VA Secretary Shulkin to expand research into the therapeutic and medicinal effects of cannabis by sending him a letter demanding for his direct involvement in making sure the medical marijuana study meets its goals.

That letter was sent on September 19th. 17 days ago.